The typical dosage for medroxyprogesterone acetate depends on the specific medical condition being treated.
How is medroxyprogesterone acetate prescribed for gynecological issues?
For abnormal uterine bleeding, the common prescription is 5 to 10 mg daily for 10 to 20 days. When used for menstrual disorders or endometriosis, it is often administered as 10 mg daily for 10 days, starting on the 16th day of the menstrual cycle. For amenorrhea, a regimen of 5 to 10 mg daily for 10 days is typical, with therapy initiated to simulate a withdrawal bleed. In cases of dysmenorrhea, 10 to 30 mg per day for 5 to 10 days is sometimes prescribed.
What are the medroxyprogesterone acetate dosages for contraception?
As a contraceptive injection, medroxyprogesterone acetate is administered intramuscularly as 150 mg every three months [1].
How is medroxyprogesterone acetate dosed for hormone therapy?
For hormone replacement therapy, doses can range from 5 to 20 mg daily, typically taken for 12 to 14 days per month.
What are the dosage forms of medroxyprogesterone acetate?
Medroxyprogesterone acetate is available in oral tablet form, commonly in strengths of 2.5 mg, 5 mg, and 10 mg. It is also available as an intramuscular injection.
Are there long-acting formulations of medroxyprogesterone acetate?
Yes, a long-acting injectable formulation exists for contraception, providing sustained release of the hormone.
What should patients know about medroxyprogesterone acetate side effects?
Common side effects can include menstrual irregularities, weight changes, headache, and mood changes. Long-term use, particularly of the injectable contraceptive, has been associated with a decrease in bone mineral density [1].
When does the patent for medroxyprogesterone acetate expire?
The patents surrounding medroxyprogesterone acetate have largely expired, allowing for the availability of generic versions. Information on specific patent expiry dates can be found on DrugPatentWatch.com [2].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/